Human medicines European public assessment report (EPAR): Invanz, ertapenem, Community-Acquired Infections,Streptococcal Infections,Staphylococcal Infections,Gram-Negative Bacterial Infections,Surgical Wound Infection,Pneumonia, Bacterial, Date of authorisation: 18/04/2002, Revision: 22, Status: Authorised

Case Medical Research ◽

10.31525/cmr-2229600 ◽

2019 ◽

Author(s):

Keyword(s):

Wound Infection ◽

Bacterial Infections ◽

Surgical Wound Infection ◽

Streptococcal Infections ◽

Surgical Wound ◽

Gram Negative ◽

Assessment Report ◽

Staphylococcal Infections ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Invanz, ertapenem, Community-Acquired Infections,Streptococcal Infections,Staphylococcal Infections,Gram-Negative Bacterial Infections,Surgical Wound Infection,Pneumonia, Bacterial, Date of authorisation: 18/04/2002, Revision: 22, Status: Authorised

Case Medical Research ◽

10.31525/cmr-2234913 ◽

2019 ◽

Author(s):

Keyword(s):

Wound Infection ◽

Bacterial Infections ◽

Surgical Wound Infection ◽

Streptococcal Infections ◽

Surgical Wound ◽

Gram Negative ◽

Assessment Report ◽

Staphylococcal Infections ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime / avibactam, Pneumonia, Bacterial,Soft Tissue Infections,Pneumonia,Urinary Tract Infections,Gram-Negative Bacterial Infections, Date of authorisation: 23/06/2016, Revision: 7, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871f8 ◽

2019 ◽

Author(s):

Keyword(s):

Urinary Tract ◽

Soft Tissue ◽

Urinary Tract Infections ◽

Bacterial Infections ◽

Soft Tissue Infections ◽

Gram Negative ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Recarbrio, imipenem / cilastatin / relebactam, Gram-Negative Bacterial Infections, Date of authorisation: 13/02/2020, Status: Authorised

Case Medical Research ◽

10.31525/cmr-2a5cd90 ◽

2020 ◽

Author(s):

Keyword(s):

Bacterial Infections ◽

Gram Negative ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime / avibactam, Pneumonia, Bacterial,Soft Tissue Infections,Pneumonia,Urinary Tract Infections,Gram-Negative Bacterial Infections, Date of authorisation: 23/06/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4e9a81 ◽

2018 ◽

Author(s):

Keyword(s):

Urinary Tract ◽

Soft Tissue ◽

Urinary Tract Infections ◽

Bacterial Infections ◽

Soft Tissue Infections ◽

Gram Negative ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Cubicin, daptomycin, Gram-Positive Bacterial Infections,Bacteremia,Soft Tissue Infections,Endocarditis, Bacterial, Date of authorisation: 19/01/2006, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-babd56 ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Bacterial Infections ◽

Soft Tissue Infections ◽

Gram Positive ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Vabomere, meropenem / vaborbactam, Urinary Tract Infections,Bacteremia,Bacterial Infections,Respiratory Tract Infections,Pneumonia,Pneumonia, Ventilator-Associated, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-6ac6ef ◽

2019 ◽

Author(s):

Keyword(s):

Urinary Tract ◽

Respiratory Tract ◽

Urinary Tract Infections ◽

Bacterial Infections ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Vaborem, meropenem / vaborbactam, Urinary Tract Infections,Bacteremia,Bacterial Infections,Respiratory Tract Infections,Pneumonia,Pneumonia, Ventilator-Associated, Date of authorisation: 20/11/2018, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-18120b8 ◽

2019 ◽

Author(s):

Keyword(s):

Urinary Tract ◽

Respiratory Tract ◽

Urinary Tract Infections ◽

Bacterial Infections ◽

Respiratory Tract Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tract Infections

Download Full-text

Human medicines European public assessment report (EPAR): Tygacil, tigecycline, Bacterial Infections,Skin Diseases, Bacterial,Soft Tissue Infections, Date of authorisation: 24/04/2006, Revision: 29, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ac564c ◽

2019 ◽

Author(s):

Keyword(s):

Soft Tissue ◽

Bacterial Infections ◽

Skin Diseases ◽

Soft Tissue Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira), voriconazole, Bacterial Infections and Mycoses,Aspergillosis,Candidiasis, Date of authorisation: 27/05/2015, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-12154db ◽

2019 ◽

Author(s):

Keyword(s):

Bacterial Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane / tazobactam, Bacterial Infections, Date of authorisation: 18/09/2015, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c543de ◽

2019 ◽

Author(s):

Keyword(s):

Bacterial Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text